Correlation Between Yamaha and Vertex Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Yamaha and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Yamaha and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Yamaha and Vertex Pharmaceuticals Incorporated, you can compare the effects of market volatilities on Yamaha and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Yamaha with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Yamaha and Vertex Pharmaceuticals.

Diversification Opportunities for Yamaha and Vertex Pharmaceuticals

-0.33

Correlation Coefficient

Yamaha  Vertex Pharmaceuticals

Very good diversification

The 3 months correlation between Yamaha and Vertex is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Yamaha and Vertex Pharmaceuticals Incorpo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Yamaha is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Yamaha are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Yamaha i.e., Yamaha and Vertex Pharmaceuticals go up and down completely randomly.

Pair Corralation between Yamaha and Vertex Pharmaceuticals

Assuming the 90 days horizon Yamaha is expected to generate 0.56 times more return on investment than Vertex Pharmaceuticals. However, Yamaha is 1.79 times less risky than Vertex Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Vertex Pharmaceuticals Incorporated is currently generating about -0.15 per unit of risk. If you would invest  650.00  in Yamaha on September 22, 2024 and sell it today you would earn a total of  2.00  from holding Yamaha or generate 0.31% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.65%
Values	Daily Returns

Yamaha  vs.  Vertex Pharmaceuticals Incorpo

Yamaha

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Yamaha has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Yamaha is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Vertex Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vertex Pharmaceuticals Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Yamaha and Vertex Pharmaceuticals

The main advantage of trading using opposite Yamaha and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Yamaha position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.

The idea behind Yamaha and Vertex Pharmaceuticals Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.